(Q47828954)

6 February 2018

title

Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement. (English)

1 reference

6 February 2018

0 references

G Murdolo

1

1 reference

6 February 2018

P Lucidi

2

1 reference

6 February 2018

C Di Loreto

3

1 reference

6 February 2018

N Parlanti

4

1 reference

6 February 2018

A De Cicco

5

1 reference

6 February 2018

C Fanelli

6

1 reference

6 February 2018

G Perriello

7

1 reference

6 February 2018

D Mughetti

8

1 reference

6 February 2018

R Pippi

9

1 reference

6 February 2018

A Brozzetti

10

1 reference

6 February 2018

F Santeusanio

11

1 reference

6 February 2018

P De Feo

12

1 reference

6 February 2018

publication date

1 March 2003

1 reference

6 February 2018

Journal of Endocrinological Investigation

published in

1 reference

6 February 2018

volume

26

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

page(s)

244-249

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1007/bf03345164

exact match

0 references

cites work

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1007%2FBF03345164

A role for ghrelin in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345164

Circulating ghrelin levels are decreased in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345164

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345164

Clinical aspects of growth hormone deficiency in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345164

Short-term treatment with low doses of recombinant human GH stimulates lipolysis in visceral obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345164

Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345164

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345164

Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345164

Weight loss increases circulating levels of ghrelin in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345164

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345164

Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345164

Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345164

Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

21 January 2018

1 reference

12 December 2020

Ghrelin strongly stimulates growth hormone release in humans

1 reference

12 December 2020

Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans

1 reference

12 December 2020

Determination of leucine and alpha-ketoisocaproic acid concentrations and specific activity in plasma and leucine specific activities in proteins using high-performance liquid chromatography

1 reference

12 December 2020

Central ghrelin production does not substantially contribute to systemic ghrelin concentrations: a study in two subjects with active acromegaly.

1 reference

12 December 2020

Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans

1 reference

12 December 2020

Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.

1 reference

12 December 2020

Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure

1 reference

12 December 2020

The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345164

1 reference

6 February 2018

PubMed ID

12809175

1 reference

6 February 2018